Mycotopia Therapies, Inc. Stock

Equities

TPIA

US62846W1071

Market Closed - OTC Markets 15:43:08 2024-05-03 EDT 5-day change 1st Jan Change
0.046 USD -23.33% Intraday chart for Mycotopia Therapies, Inc. +14.43% +187.50%
Sales 2022 - Sales 2023 - Capitalization 238K 326K
Net income 2022 -2M -2.74M Net income 2023 -1M -1.37M EV / Sales 2022 -
Net Debt 2022 269K 368K Net Debt 2023 812K 1.11M EV / Sales 2023 -
P/E ratio 2022
-0.94 x
P/E ratio 2023
-0.2 x
Employees 1
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Mycotopia Therapies, Inc. Auditor Raises 'Going Concern' Doubt CI
Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction. CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ CI
Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market CI
Mycotopia Therapies Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Mycotopia Therapies, Inc. Auditor Raises 'Going Concern' Doubt CI
Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc CI
More news
1 day-23.33%
1 week+14.43%
Current month-23.33%
1 month-66.86%
3 months+130.00%
6 months+206.67%
Current year+187.50%
More quotes
1 week
0.04
Extreme 0.0361
0.06
1 month
0.04
Extreme 0.0361
0.14
Current year
0.01
Extreme 0.0132
0.18
1 year
0.01
Extreme 0.01
0.18
3 years
0.01
Extreme 0.01
9.39
5 years
0.01
Extreme 0.01
10.00
10 years
0.01
Extreme 0.01
10.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 21-01-19
Investor Relations Contact 59 -
Members of the board TitleAgeSince
Director/Board Member 42 21-01-19
Chief Executive Officer 58 21-01-19
More insiders
Date Price Change Volume
24-05-03 0.046 -23.33% 2,872
24-04-29 0.06 +49.44% 11,000
24-04-26 0.0402 -0.37% 54,905

Delayed Quote OTC Markets, May 03, 2024 at 03:43 pm

More quotes